CAMP Gene

Last updated on: 08.08.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The CAMP gene (CAMP stands for "Cathelicidin Antimicrobial Peptide") is a protein-coding gene located on chromosome 3p21.31.

General informationThis section has been translated automatically.

The CAMP gene encodes a member of an antimicrobial peptide family characterized by a highly conserved N-terminal signal peptide with a catheline domain and a structurally variable cationic antimicrobial peptide(LL37). This is formed from the C-terminus by extracellular proteolysis.

The protein plays an important role in defending innate immunity against viruses. In addition to its antibacterial, antifungal, and antiviral activities, the encoded protein is involved in cell chemotaxis, induction of immune mediators, and regulation of inflammatory responses.

Binds to bacterial lipopolysaccharides (LPS) and has antibacterial activity (Li X Li Y et al. 2006). Acts via neutrophil N-formyl peptide receptors to increase CXCL2 release (Woloszynek JC et al 2021).

LiteratureThis section has been translated automatically.

  1. Frasca L et al (2018) Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. Front Immunol 9:1936.

  2. Garcia-Orue I et al. (2016) LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds.Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2016.04.006.

  3. Lee JB et al.(2016) Light Emitting Diodes Down-regulates Cathelicidin, Kallikrein, and Toll-like Receptor 2 Expressions in Keratinocytes and Rosacea-like Mouse Skin. Exp Dermatol doi: 10.1111/exd.13133.

  4. Li X Li Y et al (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc 1285776-5785.

  5. Woloszynek JC et al (2021) Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions. J Biol Chem 287:34101-34109.

Last updated on: 08.08.2022